Close

Highlights From Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference Part I Dec 7, 2011 09:32AM
AngioDynamics to Present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference on December 6, 2011 Nov 30, 2011 06:30AM
Canaccord Genuity Reiterates a 'Buy' on AngioDynamics (ANGO); Good Start for New CEO Oct 7, 2011 08:34AM
UPDATE - Canaccord Genuity Upgraded AngioDynamics (ANGO) to Buy; Undervalued with Positive Risk/Reward Jul 15, 2011 08:45AM
Canaccord Genuity Upgrades AngioDynamics (ANGO) to Buy Jul 15, 2011 08:08AM


Jun 14, 2011 10:50AM Notable Analyst Rating Changes 06/14: (DMD) (DRYS) (WFR) Upgraded; (SPWRA) (AAP) (ANGO) Downgraded
Jun 14, 2011 08:27AM Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Final Shoe May Have Dropped
May 25, 2011 09:06AM Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); LC Bead Exit Stymies Growth, but Still See Value
Apr 6, 2011 10:58AM Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); In-line Q3, Stock Becoming Attractive
Jan 26, 2011 12:36PM Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); FDA Warns ANGO on Off-Label Promotion of NanoKinfe
Jan 5, 2011 11:50AM Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Solid FQ2 Results Make Us Modestly More Positive
Sep 8, 2010 10:58AM Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Pre-announces Weak FQ1
Jul 16, 2010 10:58AM Canaccord Genuity Maintains a 'Neutral' on AngioDynamics (ANGO); Solid FQ4, Guidance Mixed